Dermacross Clinica Dermatologica

Vitacura 7640881

1 studies enrolling now · 3 studies all time

What they study most

Chronic Spontaneous Urticaria, Scleroderma, Systemic Sclerosis (SSc)

Studies at this site

• Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria — Enrolling by invitation
• Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) — Running, not enrolling
• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) — Running, not enrolling